ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2154

Journal of Biotechnology & Biomaterials received 2154 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Recommended Journals
Share This Page

Identification of material for development of indigenous HCV standard for qualitative nucleic acid amplification techniques, a make in India initiative

6th World Congress on Biotechnology

Manoj Kumar Rajput and Praveen Gautam

National Institute of Biologicals, India

Posters-Accepted Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.C1.044

Abstract
Background: The WHO HCV NAT international standard is being used by manufacturers of molecular in vitro diagnostics (IVDs), blood transfusion units, quality evaluation authorities and diagnostic laboratories in the validation of HCV NAT assays and to calibrate secondary reference materials. First WHO HCV NAT international standard was established in 1997 and even after 18 years of its establishment, we do not see the availability of indigenous HCV NAT standard in India. All versions of HCV NAT international standard comprised of HCV genotype-1 as per its dominancy in western countries. The purpose of this study is to identify suitable material for development of indigenous HCV NAT standard consisting of HCV genotype-3, which is dominant in larger part of India. Materials & Methods: Three HCV positive plasma bags were selected for this study. The viral load of these samples was determined. The genotypes were determined by nucleic acid sequencing. The stability studies of the material was done by incubating at different temperatures viz., 4�?° C, 25�?° C, 37�?° C and 42�?° C for a period of 90 hours. Results: Out of three, two samples were found to contain genotype-3 and one sample genotype-1 of HCV. The nucleotide sequences had been submitted to Genbank under accession no. LN681374, LN681375 and LN681380. The stability studies of these samples have been done by incubating at different temperatures viz., 4�?° C, 25�?° C, 37�?° C and 42�?° C for a period of 90 hours. After every incubation, the reduction in viral load was observed for all samples and viral load of two samples except accession no. LN681375, reduced to negligible. Conclusion: The accession no. LN681375 representing genotype-3 of HCV may considered for development for indigenous HCV standard for qualitative nucleic acid techniques, because even after incubation at 42�?° C for 90 hours, the viral load remained 196 IU/mL. Therefore, this may prove to be an indigenous affordable standard and can be transported in any area of India without cold chain.
Biography

Email: mkrajput@nib.gov.in

Top